Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Verrica Pharmaceuticals Inc. | 182,593 | reported | 25 Nov 2025 | tx 8+3,579,684 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 25 Nov 2025 | PURCHASE | Verrica Pharmaceuticals Inc. | 94,311 | 4.24 USD | first after silence |
| 25 Nov 2025 | PURCHASE | Verrica Pharmaceuticals Inc. | 23,577 | — | deriv |
| 14 Mar 2025 | GRANT_AWARD | Verrica Pharmaceuticals Inc. | 850,000 | 0.00 USD | deriv |
| 26 Nov 2024 | GIFT | Verrica Pharmaceuticals Inc. | 50,000 | 0.00 USD | |
| 22 Nov 2024 | PURCHASE | Verrica Pharmaceuticals Inc. | 280,898 | — | |
| 22 Nov 2024 | PURCHASE | Verrica Pharmaceuticals Inc. | 140,449 | — | deriv |
| 22 Nov 2024 | PURCHASE | Verrica Pharmaceuticals Inc. | 140,449 | — | deriv |
| 06 Nov 2024 | GRANT_AWARD | Verrica Pharmaceuticals Inc. | 2,000,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 25 Nov 2025.